| 000 | 01849 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515211211.0 | ||
| 264 | 0 | _c20100729 | |
| 008 | 201007s 0 0 eng d | ||
| 022 | _a1365-2141 | ||
| 024 | 7 |
_a10.1111/j.1365-2141.2010.08134.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKrishnan, Biju | |
| 245 | 0 | 0 |
_aStem cell transplantation after alemtuzumab in T-cell prolymphocytic leukaemia results in longer survival than after alemtuzumab alone: a multicentre retrospective study. _h[electronic resource] |
| 260 |
_bBritish journal of haematology _cJun 2010 |
||
| 300 |
_a907-10 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAlemtuzumab |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aAntibodies, Neoplasm _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Prolymphocytic, T-Cell _xtherapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aElse, Monica | |
| 700 | 1 | _aTjonnfjord, Geir E | |
| 700 | 1 | _aCazin, Bruno | |
| 700 | 1 | _aCarney, Dennis | |
| 700 | 1 | _aCarter, John | |
| 700 | 1 | _aKetterer, Nicolas | |
| 700 | 1 | _aCatovsky, Daniel | |
| 700 | 1 | _aEthell, Mark | |
| 700 | 1 | _aMatutes, Estella | |
| 700 | 1 | _aDearden, Claire E | |
| 773 | 0 |
_tBritish journal of haematology _gvol. 149 _gno. 6 _gp. 907-10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2141.2010.08134.x _zAvailable from publisher's website |
| 999 |
_c19569427 _d19569427 |
||